CST (n = 150a)

RSW (n = 157)

na

Weighted Mean (95% CI)

n

Weighted Mean (95% CI)

p-Value

OR (95% CI)

p-Value

GFR at 1 Year (mL/min/1.73 m2)

140

60.0 (51.7 - 68.3)

132

52.9 (50.1 - 55.8)

0.11

Living Donor

47

51.9 (41.1 - 62.7)

52

53.4 (49.4 - 57.3)

0.80

Deceased Donor

93

64.1 (53.5 - 74.7)

80

52.7 (48.7 - 56.6)

0.047

GFR at 5 Years (mL/min/1.73 m2)

49

50.7 (40.9 - 60.6)

46

52.2 (45.6 - 58.8)

0.80

Living Donor

18

42.9 (27.7 - 58.2)

21

53.4 (45.4 - 61.3)

0.23

Deceased Donor

31

55.3 (44.1 - 66.5)

25

51.3 (41.1 - 61.4)

0.59

na

Weighted% (95% CI)

n

Weighted% (95% CI)

p-Value

Delayed Graft Function

48

32% (23% - 43%)

16

10% (6% - 16%)

<0.001

0.15 (0.06 - 0.35)

<0.001

Post-Transplant Diabetes Mellitus

28

25% (14% - 41%)

22

22% (15% - 31%)

0.66

0.85 (0.32 - 2.24)

0.74

BK Viremia

16

10% (5% - 20%)

28

18% (13% - 25%)

0.15

2.72 (1.22 - 6.04)

0.014

CMV Viremia

17

11% (5% - 21%)

37

24% (18% - 31%)

0.04

4.14 (1.81 - 9.44)

0.001

Rejection at 1 Year

15

10% (5% - 18%)

51

32% (26% - 40%)

<0.001

4.26 (1.99 - 9.13)

<0.001

Rejection at 5 Year

23

15% (9% - 25%)

69

44% (36% - 52%)

<0.001

4.71 (2.40 - 9.23)

<0.001

Biopsy Proven Rejection at 1 Year

15

10% (5% - 18%)

28

18% (13% - 25%)

0.10

2.04 (0.92 - 4.55)

0.08

Biopsy Proven Rejection at 5 Year

23

15% (9% - 25%)

37

24% (18% - 31%)

0.13

1.95 (0.98 - 3.88)

0.06

Types of Rejection (Biopsy-Proven)

<0.001

Grade 1

5

22% (7% - 50%)

28

70% (54% - 82%)

Grade 2

15

68% (42% - 87%)

2

5% (1% - 18%)

Grade 3

0

0% (0% - 3%)

0

0%

Antibody-Mediated Rejection

2

9% (3% - 24%)

5

12% (5% - 27%)

Borderline Rejection

0

0% (0% - 2%)

5

12% (5% - 27%)